Ixtlan Bioscience is an Israeli based biotech company focused on developing psilocybin-based micro-dosing treatment complemented by personalized cognitive AI based exercises, aimed to open and utilize the window of plasticity for treatment of Alzheimer’s Disease and brain pathologies.
With our professional team’s expertise in neuroscience and neuropsychiatry as well as background in academic research in Alzheimer and dementia, we understand failures of the healthcare system to provide at-home neurorecovery solutions, which would provide accessibility to those unable to easily commute to receive in-person therapy.
In light of this crisis, our initial focus is developing our novel and proprietary, patent pending, Ixtlan AD Kit, for the at-home treatment of patients suffering from Alzheimer’s and dementia diseases.
We at Ixtlan envision a future where everyone has the opportunity to benefit from safe and accessible psilocybin medicine and are determined to increase the access to transformative power of these compounds.
Meet the Team
Co-founder and CEO
Former director of Novitech Education and PowerMobility. With over 10 years of experience in capital markets and practice in executing complex M&As in stock exchanges. Yehonatan is a veteran of the IDF's Special Forces.
Ana Parabucki, PhD
Co-founder and Chief Science
Neuroscientist and electrophysiologist. data science, machine learning, medical devices and novel treatments designed to help overcome CNS pathologies.
Co-founder and COO
An environmentalist and entrepreneur in Medical Psychedelic and Medical Cannabis projects which operate in regulated markets, The Founder and former CEO of Cannabics Pharmaceuticals Inc.
Ori Liraz, PhD
Neuroscientist, and Alzheimer’s disease researcher. Led numerous research projects in the field of neurodegenerative
diseases. Ori is also a games inventor with experience in product development, UX design, and more.
Christopher Freeman, MD
BOD at American Board of Mental Health Consultant. MD of public health from Tufts Uni School of Medicine, Boston. Residency in Psychiatry at Uni of Massachusetts Medical and Fellowship in Neuropsychiatry. Expertise in Alzheimer and Dementia.